|
January 5, 2006 Categories: Uncategorized Posted by admin
Angiotech is expected to announce today that it has begun a pivotal clinical trial in the United States of a central venous catheter (CVC) coated with the chemotherapy drug 5-Flourouracil (5-FU).
Full news
|
|
